As someone with acne, dark spots, scarring, and pigment changes are honestly the most frustrating part for me. I can clear all of my acne but still be stuck with these spots on my face for months ...
Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment
This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback